Zusammenfassung
Regionale Unterschiede in der Hypertonieprävalenz in Deutschland konnten bereits anhand von Bevölkerungsstichproben sowohl im Ost-West- als auch im Nord-Süd-Vergleich beschrieben werden. So stellte sich im Vergleich der norddeutschen SHIP-Studie (1997–2001) mit der süddeutschen MONICA/KORA-S4-Studie (1999–2001) eine signifikant höhere altersadjustierte Prävalenz in der norddeutschen Bevölkerung dar. Die Heinz Nixdorf Recall Studie ist eine populationsbasierte prospektive Beobachtungsstudie, die Quer- und Längsschnittdaten zu Risikofaktoren, Zeichen der subklinischen Arteriosklerose und kardiovaskulären Endpunkten im Ruhrgebiet erhebt. Von den zwischen 2000 und 2003 eingeschlossenen Probanden zwischen 45 und 75 Jahren ohne bekannte koronare Gefäßerkrankung mit vollständigen Angaben zur antihypertensiven Therapie (n=4.443) wiesen 63% der Männer und 52% der Frauen eine arterielle Hypertonie auf. Niedrige Erkennungs-, Behandlungs- und Kontrollraten in Bevölkerungsstichproben sowie in aktuellen Kohorten von Patienten mit koronarer Gefäßerkrankung in Deutschland verdeutlichen die Notwendigkeit optimierter Screening-, Therapie- und Nachsorgemaßnahmen sowohl in der Primär- als auch in der Sekundärprävention. Eine erweiterte Risikostratifizierung, z. B. mittels Bestimmung der koronaren Gefäßverkalkung, könnte zu einer besseren Vorhersage des Risiko-Nutzen-Verhältnisses einer präventiven Therapieeinleitung oder -intensivierung führen.
Abstract
Regional disparities in the prevalence of arterial hypertension in Germany have been reported in population-based surveys. An analysis comparing the SHIP study in the north-eastern region of Germany (1997–2001) with the MONICA/KORA-S4 study (1999–2001) in the south-west of Germany showed a significantly higher age-adjusted prevalence in the north-eastern population. The Heinz Nixdorf Recall Study is a population based prospective cohort study designed to assess cross-sectional and longitudinal data of risk factors, subclinical signs of atherosclerosis and cardiovascular endpoints in the Ruhr area of Germany. A total of 4,443 subjects without coronary artery disease aged 45–75 years could be included between 2000 und 2003 and the prevalence of hypertension, defined by JNC-7, was 63% in men and 52% in women. Low rates of hypertension awareness, treatment and control rates in population-based surveys as well as in recently published high risk cohorts with known coronary artery disease in Germany elucidate the need to optimize the strategies of screening, treatment and follow-up in primary and secondary prevention. Coronary artery calcification was demonstrated to be an independent risk factor for cardiovascular endpoints even in the stage of prehypertension. The risk-benefit ratio for an early treatment of these patients could be improved by advanced risk stratification, assessing the level of coronary artery calcification.
Literatur
Assmann G, Schulte H, Cullen P (1997) New and classical risk factors – the Munster heart study (PROCAM). Eur J Med Res 2(6):237–242
Kannel WB (1990) CHD risk factors: a Framingham study update. Hosp Pract (Off Ed) 25(7):119–127, 130
Keil U, Liese AD, Hense HW et al (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Monitoring trends and determinants in cardiovascular diseases. Eur Heart J 19(8):1197–1207
Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 223(1):1–68
World Health Organisation (2005) The European Health Report 2005: public health action for healthier children and populations. Statistical tables. World Health Organisation, Copenhagen
Chalmers J, MacMahon S, Mancia G et al (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 21(5–6):1009–1060
Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560–2572
Mancia G, De BG, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28(12):1462–1536
Erbel R, Lehmann N, Mohlenkamp S et al (2012) Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension 59(1):44–53
Schmermund A, Mohlenkamp S, Stang A et al (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 144(2):212–218
Stang A, Moebus S, Dragano N et al (2005) Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response. Eur J Epidemiol 20(6):489–496
Erbel R, Eisele L, Moebus S et al (2012) The Heinz Nixdorf Recall Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6–7):809–815
Stang A, Moebus S, Mohlenkamp S et al (2006) Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 164(1):85–94
Garrow JS (1963) Zero-muddler for unprejudiced sphygmomanometry. Lancet 2(7319):1205
Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355(9205):675–687
Vargas CM, Ingram DD, Gillum RF (2000) Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol 152(3):272–278
Wilsgaard T, Jacobsen BK, Schirmer H et al (2001) Tracking of cardiovascular risk factors: the Tromso study, 1979–1995. Am J Epidemiol 154(5):418–426
Hofman A, Grobbee DE, Jong PT de et al (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7(4):403–422
Vasan RS, Larson MG, Leip EP et al (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345(18):1291–1297
Conroy RM, O’Brien E, O’Malley K et al (1993) Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn? BMJ 306(6888):1319–1322
Evans JG, Prior IA (1970) Experience with the random-zero sphygmomanometer. Br J Prev Soc Med 24(1):10–15
Lawson M, Johnston A (1993) The Hawksley random zero sphygmomanometer. Should be abandoned. BMJ 307(6896):123
McGurk C, Nugent A, McAuley D et al (1997) Sources of inaccuracy in the use of the Hawksley random-zero sphygmomanometer. J Hypertens 15(12 Pt 1):1379–1384
O’Brien E, Mee F, Atkins N et al (1990) Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 336(8729):1465–1468
O’Brien E, Waeber B, Parati G et al (2001) Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 322(7285):531–536
Mackie A, Whincup P, McKinnon M (1995) Does the Hawksley random zero sphygmomanometer underestimate blood pressure, and by how much? J Hum Hypertens 9(5):337–343
Erbel R, Mohlenkamp S, Jockel KH et al (2008) Cardiovascular risk factors and signs of subclinical atherosclerosis in the Heinz Nixdorf Recall Study. Dtsch Arztebl Int 105(1–2):1–8
Churzidse S (2008) Abhängigkeit der subklinischen Atherosklerose der Koronargefäße von der Höhe des Blutdruckes und Cholesterinspiegels. Die Ergebnisse der Heinz Nixdorf Recall Studie [Dissertation], Medizinische Fakultät der Universität Duisburg-Essen, Westdeutsches Herzzentrum Essen, Klinik für Kardiologie
Stang A, Moebus S, Möhlenkamp S et al (2004) Prevalence and determinants of arterial hypertension in the Ruhrarea: Results of the Heinz Nixdorf Recall Study. Meeting Abstract, 49. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds)
Erbel R, Mohlenkamp S, Moebus S et al (2010) Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 56(17):1397–1406
Meisinger C, Heier M, Volzke H et al (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24(2):293–299
Thamm M (1999) Blood pressure in Germany – current status and trends. Gesundheitswesen 61 Spec No:90–93
Lowel H, Meisinger C, Heier M et al (2006) Epidemiology of hypertension in Germany. Selected results of population-representative cross-sectional studies. Dtsch Med Wochenschr 131(46):2586–2591
Gasse C, Hense HW, Stieber J et al (2001) Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984–1995. J Hum Hypertens 15(1):27–36
Evans A, Tolonen H, Hense HW et al (2001) Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol 30(Suppl 1):35–40
Volzke H (2012) Study of Health in Pomerania (SHIP): concept, design and selected results. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6–7):790–794
Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289(18):2363–2369
Erbel R, Delaney JA, Lehmann N et al (2008) Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR). Eur Heart J 29(22):2782–2791
Bild DE, Bluemke DA, Burke GL et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871–881
Prugger C, Heidrich J, Wellmann J et al (2012) Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Munster region. Dtsch Arztebl Int 109(17):303–310
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Additional information
Anmerkung: Die vorliegende Arbeit enthält unveröffentlichte Daten der Dissertation von Frau Dr. med. S. Churzidse [28].
Rights and permissions
About this article
Cite this article
Horacek, M., Möhlenkamp, S., Mahabadi, A. et al. Prävalenz der arteriellen Hypertonie in der westdeutschen Bevölkerung. Herz 37, 721–727 (2012). https://doi.org/10.1007/s00059-012-3684-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-012-3684-z